drugset
drugset / Trial / NCT03297021

Effects of Ondansetron Dose and Timing on Post-operative Nausea and Vomiting

NCT03297021 ↗

Phase 4 Completed 141 enrolled Icahn School of Medicine at Mount Sinai
RandomizedFactorialTriple-blindPrevention

Summary

The aim is to evaluate the effectiveness of three different regimens of prophylactic ondansetron on the incidence and severity of post-operative nausea and vomiting.

Timeline

Start
2017-10-23
Primary completion
2019-04-05
Completion
2019-04-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Ondansetron Other / unclassified 4 mg —
Subject Ondansetron Other / unclassified 8 mg —

Indications

No indication recorded.